ZA200710312B - An oligonucleotide or its functional homologue, a composition comprising the same and a method for treating B Cell neoplasm - Google Patents

An oligonucleotide or its functional homologue, a composition comprising the same and a method for treating B Cell neoplasm

Info

Publication number: ZA200710312B
Authority: ZA; South Africa
Prior art keywords: oligonucleotide; treating; composition; same; cell neoplasm
Prior art date: 2005-05-17

Application number

ZA200710312A

Other languages

English (en)

Inventor

Wang Li-Ying

Bao Mu-Sheng

Yu Yong-Li

Original Assignee

Changchun Huapu Biotechnology

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-05-17

Filing date

2006-02-13

Publication date

2009-08-26

2006-02-13 Application filed by Changchun Huapu Biotechnology filed Critical Changchun Huapu Biotechnology

2009-08-26 Publication of ZA200710312B publication Critical patent/ZA200710312B/xx

Links

208000012526 B-cell neoplasm Diseases 0.000 title 1
108091034117 Oligonucleotide Proteins 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/117—Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/17—Immunomodulatory nucleic acids
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/313—Phosphorodithioates
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/315—Phosphorothioates

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
General Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Biochemistry (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Immunology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Biophysics (AREA)
Microbiology (AREA)
Plant Pathology (AREA)
Physics & Mathematics (AREA)
Epidemiology (AREA)
Hematology (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Saccharide Compounds (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

ZA200710312A 2005-05-17 2006-02-13 An oligonucleotide or its functional homologue, a composition comprising the same and a method for treating B Cell neoplasm ZA200710312B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CN2005100695764A CN1865275B (zh)	2005-05-17	2005-05-17	对人b细胞肿瘤有治疗作用的人工合成的单链脱氧核苷酸

Publications (1)

Publication Number	Publication Date
ZA200710312B true ZA200710312B (en)	2009-08-26

Family

ID=37424439

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
ZA200710312A ZA200710312B (en)	2005-05-17	2006-02-13	An oligonucleotide or its functional homologue, a composition comprising the same and a method for treating B Cell neoplasm
ZA200710311A ZA200710311B (en)	2005-05-17	2006-02-13	Oligonucleotides or their functional homologues, a composition comprising the same and a method of treating B cell neoplasm

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
ZA200710311A ZA200710311B (en)	2005-05-17	2006-02-13	Oligonucleotides or their functional homologues, a composition comprising the same and a method of treating B cell neoplasm

Country Status (21)

Country	Link
US (3)	US20090202567A1 (uk)
EP (2)	EP1883411B1 (uk)
JP (2)	JP4837033B2 (uk)
KR (2)	KR101294131B1 (uk)
CN (1)	CN1865275B (uk)
AU (2)	AU2006246898B2 (uk)
BR (2)	BRPI0609885A2 (uk)
CA (2)	CA2609067A1 (uk)
CY (1)	CY1114844T1 (uk)
DK (2)	DK1883647T3 (uk)
ES (2)	ES2433129T3 (uk)
IL (2)	IL187249A (uk)
MX (2)	MX2007014145A (uk)
NZ (1)	NZ563582A (uk)
PL (2)	PL1883647T3 (uk)
PT (2)	PT1883647E (uk)
RU (2)	RU2413519C2 (uk)
SI (2)	SI1883411T1 (uk)
UA (2)	UA91057C2 (uk)
WO (2)	WO2006122463A1 (uk)
ZA (2)	ZA200710312B (uk)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2728276A1 (en) *	2008-06-18	2009-12-23	Index Pharmaceuticals Ab	Combination therapies against cancer
CN101643496B (zh) *	2008-08-07	2015-09-09	长春华普生物技术有限公司	一种具有免疫抑制功能的寡核苷酸
US20110280934A1 (en) *	2008-11-04	2011-11-17	Asa Karlsson	Increased Expression of Specific Antigens
WO2012084991A1 (en) *	2010-12-21	2012-06-28	Index Pharmaceuticals Ab	Biologically active oligonucleotides capable of modulating the immune system ii
US9157919B2 (en) *	2010-12-21	2015-10-13	Index Pharmaceuticals Ab	Method for identifying biologically active oligonucleotides capable of modulating the immune system
CN106893724B (zh) *	2015-12-17	2023-05-02	苏州派动生物技术有限公司	具有抗原增效作用和肿瘤治疗作用的寡核苷酸
WO2021249011A1 (en)	2020-06-10	2021-12-16	Sichuan Clover Biopharmaceuticals, Inc.	Hiv vaccine compositions, methods, and uses thereof
WO2021249116A1 (en)	2020-06-10	2021-12-16	Sichuan Clover Biopharmaceuticals, Inc.	Coronavirus vaccine compositions, methods, and uses thereof
AU2024280139A1 (en)	2023-05-30	2026-01-22	Sichuan Clover Biopharmaceuticals, Inc.	Coronavirus vaccine composition, method therefor and use thereof
CN121464149A (zh)	2023-06-07	2026-02-03	四川三叶草生物制药有限公司	Rsv疫苗组合物、方法及其用途

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5736137A (en) *	1992-11-13	1998-04-07	Idec Pharmaceuticals Corporation	Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
DE19651443A1 (de) *	1996-12-11	1998-06-18	Hoechst Ag	Selbstverstärkende, pharmakologisch kontrollierbare Expressionssysteme
ATE297219T1 (de) *	1997-02-12	2005-06-15	Chugai Pharmaceutical Co Ltd	Antikörper als arzneimittel gegen lymphocytische tumore (ausschliesslich myelome)
NZ517929A (en)	1999-09-25	2004-02-27	Univ Iowa Res Found	Immunostimulatory nucleic acids
WO2001074388A1 (en) *	2000-03-31	2001-10-11	Idec Pharmaceuticals Corporation	Combined use of anti-cytokine antibodies or antagonists and anti-cd20 for the treatment of b cell lymphoma
EP1296714B1 (en)	2000-06-22	2009-08-26	University Of Iowa Research Foundation	Combination of CpG and antibodies directed against CD19,CD20, CD22 or CD40 for the treatment or prevention of cancer.
US20040009156A1 (en) *	2001-10-12	2004-01-15	Christoph Reinhard	Antisense therapy using oligonucleotides that target human kinesin genes for treatment of cancer
EP1465634B1 (en)	2001-12-12	2014-10-22	The Government of the United States of America, as represented by the Secretary Department of Health and Human Services	Methods for using adenosine receptor inhibitors to enhance immune response and inflammation
US7576066B2 (en) *	2002-07-03	2009-08-18	Coley Pharmaceutical Group, Inc.	Nucleic acid compositions for stimulating immune responses
DE10258677A1 (de) *	2002-12-13	2004-06-24	Elez, Vera, Dr.	Kombinations-antisense-Oligonukleotid-Krebstherapie
CN100439386C (zh) *	2003-03-05	2008-12-03	长春华普生物技术有限公司	增强蛋白类疫苗免疫效果的含CpG单链脱氧寡核苷酸
CN100486987C (zh) *	2003-03-05	2009-05-13	长春华普生物技术有限公司	抗病毒和抗肿瘤的含CpG单链脱氧寡核苷酸
DE10333509B4 (de) *	2003-07-18	2007-05-03	Technische Universität Dresden	Gegen VEGF gerichtete Erkennungsmoleküle und die Verwendung dieser
US7491706B2 (en)	2003-07-25	2009-02-17	Changchun Huapu Biotechnology Co., Ltd.	Artificial cpg single-stranded oligodeoxynucleotide and antiviral use thereof
JP4513879B2 (ja)	2008-03-05	2010-07-28	ソニー株式会社	像ぶれ補正装置、レンズ鏡筒装置及びカメラ装置

2005
- 2005-05-17 CN CN2005100695764A patent/CN1865275B/zh not_active Expired - Lifetime
2006
- 2006-02-13 CA CA002609067A patent/CA2609067A1/en not_active Abandoned
- 2006-02-13 JP JP2008511531A patent/JP4837033B2/ja not_active Expired - Fee Related
- 2006-02-13 US US11/914,744 patent/US20090202567A1/en not_active Abandoned
- 2006-02-13 ZA ZA200710312A patent/ZA200710312B/xx unknown
- 2006-02-13 PL PL06705636T patent/PL1883647T3/pl unknown
- 2006-02-13 AU AU2006246898A patent/AU2006246898B2/en not_active Ceased
- 2006-02-13 ES ES06705637T patent/ES2433129T3/es not_active Expired - Lifetime
- 2006-02-13 SI SI200631687T patent/SI1883411T1/sl unknown
- 2006-02-13 WO PCT/CN2006/000215 patent/WO2006122463A1/en not_active Ceased
- 2006-02-13 PL PL06705637T patent/PL1883411T3/pl unknown
- 2006-02-13 KR KR1020077028308A patent/KR101294131B1/ko not_active Expired - Fee Related
- 2006-02-13 MX MX2007014145A patent/MX2007014145A/es active IP Right Grant
- 2006-02-13 NZ NZ563582A patent/NZ563582A/en not_active IP Right Cessation
- 2006-02-13 CA CA2609062A patent/CA2609062C/en not_active Expired - Fee Related
- 2006-02-13 UA UAA200714103A patent/UA91057C2/uk unknown
- 2006-02-13 DK DK06705636.6T patent/DK1883647T3/da active
- 2006-02-13 EP EP06705637.4A patent/EP1883411B1/en not_active Expired - Lifetime
- 2006-02-13 AU AU2006246897A patent/AU2006246897B2/en not_active Ceased
- 2006-02-13 RU RU2007146705/14A patent/RU2413519C2/ru not_active IP Right Cessation
- 2006-02-13 MX MX2007014146A patent/MX2007014146A/es active IP Right Grant
- 2006-02-13 US US11/914,745 patent/US8133874B2/en active Active
- 2006-02-13 RU RU2007146706/10A patent/RU2409672C2/ru not_active IP Right Cessation
- 2006-02-13 KR KR1020077028065A patent/KR101346716B1/ko not_active Expired - Fee Related
- 2006-02-13 EP EP06705636.6A patent/EP1883647B1/en not_active Expired - Lifetime
- 2006-02-13 SI SI200631728T patent/SI1883647T1/sl unknown
- 2006-02-13 BR BRPI0609885-1A patent/BRPI0609885A2/pt not_active IP Right Cessation
- 2006-02-13 UA UAA200714106A patent/UA94231C2/uk unknown
- 2006-02-13 JP JP2008511532A patent/JP4837034B2/ja not_active Expired - Fee Related
- 2006-02-13 ES ES06705636.6T patent/ES2442462T3/es not_active Expired - Lifetime
- 2006-02-13 PT PT67056366T patent/PT1883647E/pt unknown
- 2006-02-13 ZA ZA200710311A patent/ZA200710311B/xx unknown
- 2006-02-13 PT PT67056374T patent/PT1883411E/pt unknown
- 2006-02-13 BR BRPI0609882-7A patent/BRPI0609882A2/pt not_active IP Right Cessation
- 2006-02-13 DK DK06705637.4T patent/DK1883411T3/da active
- 2006-02-13 WO PCT/CN2006/000216 patent/WO2006122464A1/en not_active Ceased
2007
- 2007-11-08 IL IL187249A patent/IL187249A/en not_active IP Right Cessation
- 2007-11-08 IL IL187281A patent/IL187281A/en not_active IP Right Cessation
2011
- 2011-12-02 US US13/310,595 patent/US8450292B2/en not_active Expired - Fee Related
2014
- 2014-01-13 CY CY20141100024T patent/CY1114844T1/el unknown

Also Published As

Publication number	Publication date
MX2007014145A (es)	2008-03-07
PT1883647E (pt)	2014-01-20
US8450292B2 (en)	2013-05-28
CA2609062C (en)	2013-11-19
ZA200710311B (en)	2009-08-26
EP1883411B1 (en)	2013-08-14
RU2409672C2 (ru)	2011-01-20
JP2008539768A (ja)	2008-11-20
MX2007014146A (es)	2008-03-07
HK1113318A1 (en)	2008-10-03
SI1883411T1 (sl)	2014-01-31
KR20080007655A (ko)	2008-01-22
WO2006122463A1 (en)	2006-11-23
CA2609067A1 (en)	2006-11-23
RU2007146705A (ru)	2009-06-27
PL1883647T3 (pl)	2014-03-31
KR101294131B1 (ko)	2013-08-07
IL187281A0 (en)	2011-08-01
CY1114844T1 (el)	2016-12-14
KR20080011426A (ko)	2008-02-04
US8133874B2 (en)	2012-03-13
BRPI0609885A2 (pt)	2010-05-04
UA94231C2 (uk)	2011-04-26
ES2433129T3 (es)	2013-12-09
PT1883411E (pt)	2013-11-11
BRPI0609882A2 (pt)	2010-05-04
RU2007146706A (ru)	2009-06-27
SI1883647T1 (sl)	2014-02-28
IL187249A0 (en)	2008-02-09
CA2609062A1 (en)	2006-11-23
US20120142761A1 (en)	2012-06-07
JP2008539767A (ja)	2008-11-20
DK1883647T3 (da)	2014-01-27
AU2006246897A1 (en)	2006-11-23
EP1883647A4 (en)	2010-10-06
ES2442462T3 (es)	2014-02-11
JP4837033B2 (ja)	2011-12-14
DK1883411T3 (da)	2013-11-18
EP1883647B1 (en)	2013-10-23
EP1883411A4 (en)	2010-10-06
PL1883411T3 (pl)	2014-01-31
RU2413519C2 (ru)	2011-03-10
US20090162279A1 (en)	2009-06-25
US20090202567A1 (en)	2009-08-13
AU2006246898A1 (en)	2006-11-23
CN1865275B (zh)	2011-06-15
HK1112745A1 (en)	2008-09-12
AU2006246897B2 (en)	2012-04-12
UA91057C2 (uk)	2010-06-25
WO2006122464A1 (en)	2006-11-23
EP1883647A1 (en)	2008-02-06
IL187281A (en)	2012-04-30
KR101346716B1 (ko)	2014-01-02
IL187249A (en)	2012-03-29
EP1883411A1 (en)	2008-02-06
NZ563582A (en)	2010-04-30
CN1865275A (zh)	2006-11-22
AU2006246898B2 (en)	2011-08-18
JP4837034B2 (ja)	2011-12-14

Publication	Publication Date	Title
GB2428035B (en)	2007-08-29	Handling system, work system and program
TWI347496B (en)	2011-08-21	Lithographic device, and method
PL1651042T3 (pl)	2016-09-30	Kompozycja chwastobójcza o zwiększonym działaniu chwastobójczym i sposób zwiększania działania chwastobójczego
IL191556A0 (en)	2008-12-29	Solar system and method for the operation thereof
EP1869632A4 (en)	2010-01-27	SYSTEM AND METHOD OF USE BASED ON CORRESPONDENCE
EP2084745A4 (en)	2012-10-24	DEVICE AND METHOD FOR THE PRODUCTION THEREOF
EP1939738A4 (en)	2010-03-24	SYSTEM, METHOD AND PROGRAM FOR TREATING RULES
IL214183A (en)	2015-03-31	Pharma-informatics system and method, preparation for use with it and method for preparation of the preparation
IL185783A0 (en)	2008-01-06	Accumulator and method for the operation thereof
EG25122A (en)	2011-09-18	Method and device for metering medicaments.
IL186855A0 (en)	2008-02-09	Identity document and method for the manufacture thereof
IL187249A0 (en)	2008-02-09	An oligonucleotide or its functional homologue, a composition comprising the same and a method of treating b cell nemoplasm
EP1889726A4 (en)	2010-02-17	PRINTING DEVICE, PRINTING SYSTEM, PROGRAM AND PRINTING METHOD
TWI372776B (en)	2012-09-21	Aqueous primer composition, method for treating substrate using the same, and laminated structure using the same
GB0809514D0 (en)	2008-07-02	Vehicle coating method and coating line.
EP1965206A4 (en)	2013-03-27	CORROSION EVALUATION DEVICE AND METHOD
EP1923784A4 (en)	2010-02-17	SCHEDULING PROCEDURE AND SCHEDULING EQUIPMENT
TWI367504B (en)	2012-07-01	Ceramic component element, ceramic component and method for the same
GB2435749B (en)	2009-02-18	Loss compensation device, loss compensation method, and loss compensation program
EP1865607A4 (en)	2011-05-04	REDUCING DEVICE AND METHOD AND RECEIVING DEVICE
EP1762175A4 (en)	2010-12-01	BIOPHOTOMETER, BIOPHOTOMETRY AND PROGRAM
EP2056189A4 (en)	2009-11-11	PORTABLE DEVICE, FUNCTION LIST PROVISION METHOD FOR THIS AND PROGRAM THEREFOR
GB0603062D0 (en)	2006-03-29	Method, composition and articles
IL194689A0 (en)	2011-08-01	Agent, composition and method
EP1950038A4 (en)	2010-03-03	PRINT MANAGEMENT SYSTEM, METHOD AND PROGRAM